Together, our study provides a novel circadian rhythm-related signature for prognostic stratification and immune phenotype prediction in LUAD, offering mechanistic insights into CRG-mediated tumor-immune interactions and potential avenues for integrating circadian biology into cancer immunotherapy. This evidence concerns the gene CHD7 and neoplasm.